| Scenario | When It Happens | Implications |
| 1. Left in place (most common) | No significant risk; stable size/function | May produce urine (residual function); monitor for infection, stones, hypertension; can affect drug clearance |
| 2. Removed before/during transplant | High-risk features present | Eliminates: recurrent infection source, renin-mediated HTN, protein loss, malignancy risk, cyst hemorrhage; adds surgical risk |
| 3. Removed later | Complications arise post-transplant | Same indications as #2 but delayed; higher surgical risk with immunosuppression |
Indications for Native Nephrectomy
- **Recurrent pyelonephritis** in native kidneys (seeding graft).
- **Uncontrolled hypertension** from native renin (especially polycystic kidneys).
- **Massive proteinuria** → volume depletion, thrombosis risk.
- **Large symptomatic cysts** (pain, hemorrhage, infection) — ADPKD.
- **Malignancy** (RCC in cystic kidneys; incidence ↑ post-transplant).
- **Reflux nephropathy** with high-grade VUR.
- **Space constraints** (small pelvis, pediatric en bloc grafts).
If Native Kidneys Stay
- **Monitor:** Urinalysis, culture if symptomatic; BP; renal ultrasound annually.
- **Drug dosing:** Residual native function contributes to clearance — adjust renally cleared drugs (e.g., some antibiotics, antivirals).
- **Contrast caution:** Native kidneys still at risk for CIN.
- **Pregnancy:** Native kidneys + graft = complex hemodynamic management.
Decision-Making
Multidisciplinary: transplant surgeon, nephrologist, urologist, anesthesiology. Weighs:
- Native kidney pathology (imaging, biopsy if indicated).
- Graft function trajectory.
- Patient comorbidities, surgical risk.
- Patient preference.
Key Takeaway
Most keep native kidneys. Removal is targeted, not routine. Ongoing surveillance balances risks of retention vs. surgery.
Kidney Disease - Related Articles